Senate Bill 2356
118th Congress(2023-2024)
Gene Synthesis Safety and Security Act
Introduced
Introduced in Senate on Jul 18, 2023
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2356
Congress
118
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No Senate votes have been held for this bill.
Summary
Gene Synthesis Safety and Security Act
This bill requires the Department of Health and Human Services (HHS) to update guidance to address the potential misuse of gene synthesis products (i.e., manufactured genetic products) to obtain biological agents or toxins of concern.
The guidance must include recommendations relating to screening protocols, recordkeeping, technological safeguards, and other specified information. HHS must evaluate the current landscape of gene synthesis manufacturers and related technology to inform the guidance. HHS must also solicit public input to develop a list of genetic sequences of concern.
July 18, 2023
Sort by most recent
07/18/2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
07/18/2023
Introduced in Senate
Public Record
Record Updated
Oct 4, 2024 4:39:04 PM